CBLI - Cytocom Inc
Previous close
3.12
0 0%
Share volume: 0
Last Updated: Wed 01 Sep 2021 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.12
0.00
0.00%
Summary score
33%
Profitability
43%
Dept financing
25%
Liquidity
75%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2017 - 2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-41.55%
Return on assets
-18.26%
Return on sales
-489.28%
Return on invested capital
93.37%
Total debt ratio
153.16%
Debt ratio change over timeo
1.26%
Current Ratio
5.79%
Quick Ratio
5.91%
Cash Position Ratio
5.11%
Short-term ratios 2020 - 2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
18.2%
Return on assets
-18.93%
Return on sales
-1353.76%
Return on invested capital
134.9%
Total debt ratio
143.93%
Debt ratio change over timeo
0.55%
Current Ratio
11.95%
Quick Ratio
11.95%
Cash Position Ratio
11.68%
Last quarter ratios 2021
The data are presented for the financials results of the last quarter.
Return on equity
-5.84%
Return on assets
-3.75%
Return on sales
0%
Return on invested capital
105.1%
Total debt ratio
37.28%
Debt ratio change over time
-0.65%
Current Ratio
28.36%
Quick Ratio
28.36%
Cash Position Ratio
28.22%
Performance ratios (change over 4 years) 2017 - 2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-160.16%
Return on assets
-126.53%
Return on sales
-660.75%
Return on invested capital
30.07%
Total debt ratio
125.99%
Debt ratio change over time
1.26%
Current Ratio
6%
Quick Ratio
6.29%
Cash Position Ratio
5.18%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CBLI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -41.55% | -6.02% | 13.65% | 6.98% |
| Return on assets | -18.26% | 3.39% | 3.61% | 5.41% |
| Return on sales | -489.28% | 30.6% | 40.46% | 35.45% |
| Return on invested capital | 93.37% | 4.76% | 7.3% | 15.54% |
| Profitability | 25% | 36% | 69% | 64% |
| Total debt ratio | 153.16% | 100.95% | 78.51% | 29.4% |
| Debt ratio change over time | 1.26% | 258.46% | 7.2% | 1.53% |
| Dept financing | 25% | 41% | 14% | 5% |
| Current Ratio | 11.95% | 0.87% | 1.98% | 3.19% |
| Quick Ratio | 11.95% | 0.74% | 1.63% | 2.54% |
| Cash Position Ratio | 11.68% | 0.29% | 0.88% | 1.14% |
| Liquididy | 75% | 14% | 29% | 36% |
| Short-term ratios | CBLI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 18.2% | 8.95% | 17.54% | 9.49% |
| Return on assets | -18.93% | 2.19% | 3.45% | 5.63% |
| Return on sales | -1353.76% | 25.57% | 35.22% | 39.9% |
| Return on invested capital | 134.9% | 1.34% | 5.79% | 24.68% |
| Profitability | 50% | 38% | 63% | 68% |
| Total debt ratio | 143.93% | 90.54% | 84.19% | 35.66% |
| Debt ratio change over time | 0.55% | 1037.1% | 13.92% | 1.92% |
| Dept financing | 25% | 41% | 15% | 6% |
| Current Ratio | 11.95% | 0.87% | 1.98% | 3.19% |
| Quick Ratio | 11.95% | 0.74% | 1.63% | 2.54% |
| Cash Position Ratio | 11.68% | 0.29% | 0.88% | 1.14% |
| Liquididy | 75% | 4% | 9% | 14% |